documents: FDA-2022-E-0249-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-E-0249-0005 FDA FDA-2022-E-0249 Determination of Regulatory Review Period for Purposes of Patent Extension; Pemazyre Notice Determinations 2023-12-08T05:00:00Z 2023 12 2023-12-08T05:00:00Z 2024-02-07T04:59:59Z 2023-12-08T14:50:24Z 2023-26996 0 0 0900006486317518

Links from other tables